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Sepsis in oncologic patients is a serious complica­
tion in the course of primary treatment. Surgery, often 
an extensive one, involves opening of the digestive 
tract, urinary tract, anastomosis of the colon, use of 
vascular lines, catheters in the bladder, parenteral nutri­
tion, stay in the ICU, immunocompromised immune 
systems, and favours systemic infections (Encina et al. 
2016; Alkhamis et al., 2014; Smit et al., 2016; Mahdi 
et al., 2014). Generalized infections in cancer patients 
are burdened with high mortality; therefore, time is 
one of the important factors in their diagnosis and 
treatment (Namendys­Silva et al., 2010; Rosolem et al., 
2012). Classic diagnosis of these infections, including 
identification, determination of antibiotic susceptibility 
and detection of resistance mechanisms of the cultured 
microorganisms, takes 2–5 days from the delivery of 
samples for microbiological examination. Due to the 
relatively long period of waiting for the test results, 
empiric therapy is implemented. The etiologic agent is 
often not grown, due to the sensitivity of the culture 
method. Empiric therapy carries the risk of not includ­
ing the etiologic agent of the infection within its cov­
erage, it can lead to overuse of antibiotics with a wide 
spectrum, prolongs hospitalization, increases the cost of 
treatment, and selects for multidrug­resistant strains in 
units of health care, which ultimately leads to increased 
mortality (Kumar, 2011). 
In 2013, the Food and Drug Administration (FDA) 
issued a positive opinion on a FilmArray® Blood Cul­
ture Identification Panel (BCID) (BioFire Diagnostics, 
Salt Lake City, UT) for rapid identification of aerobic 
microorganisms in positive blood culture. The applica­
tion of the multiplex PCR method in the diagnosis of 
bloodstream infections is designed to reduce the time 
for identification of the microorganisms grown from 
the positive samples to 24–48 hours, as pathogens are 
identified directly from a positive blood sample.
There have been several papers published on the 
usefulness of the test in diagnosis of sepsis in adults, 
children and patients undergoing organ transplanta­
tion in relation to conventional methods, but there are 
no papers defining the efficacy of the test in diagnosis 
of bloodstream infections in cancer patients, including 
patients after surgery (Blaschke et al., 2012; Zheng et al., 
2014; Otlu et al., 2015). 
The aim of the study was to compare two methods 
of identification of microorganisms from positive blood 
cultures: the classical method – culture and the genetic 
method – multiplex PCR as well as the time from the 
receipt of positive samples to communicating the result 
of PCR and uploading the microbiological report into 
the hospital information system. 
The examination involved 70 positive blood sam­
ples obtained in BacT/Alert 3D instrument, between 
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August 2015 and November 2016. Diagnostic mate­
rials were collected from 55 patients suffering from 
cancers, who were treated in clinical departments of 
Prof.  F. Łukaszczyk Oncology Centre in Bydgoszcz. 
Among the patients from which blood was drawn, 
40  patients (72.7%) were treated surgically, with dif­
ferent extensity of the surgical procedure, including 
pelvic exenteration in the case of advanced ovarian 
cancer, and 15 patients (27.3%) underwent conserva­
tive treatment. Positive aerobic blood cultures, con­
firmed by the microscopic preparation stained with 
the Gram method, underwent multiplex PCR analysis 
with the use of BCID. Microorganisms and resistance 
genes covered by BCID are presented in Table I. Posi­
tive blood cultures were also passaged on solid media 
and the isolated microorganisms were identified and 
analysed for antibiotic susceptibility with the use of 
VITEK  2 Compact and E­test® system (bioMérieux, 
USA). Due to the fact that there is a  12­hours shift 
system in the Microbiology Department, 13 test sam­
ples (18.6%) underwent genetic analysis in more than 
8  hours after the signal from BacT/Alert 3D instru­
ment was observed. Valida tion of the method did not 
confirm that the extension of bottles incubation time 
to 15 hours had a negative impact on the reliability of 
the results. As a gold standard, the culture method was 
used in the research. Quantitative data were developed 
with the use of U Mann­Whitney test, value p < 0.05 
was acknowledged as statistically significant. 
Eighty­nine isolates were cultured from 70 samples. 
In 55 (78.6%) cultures microbial growth in monocul­
ture was obtained. The multiplex PCR assay revealed 
all bacterial species and types present in positive blood 
cultures bottles that have been included in the panel. 
However, for two isolates identified using BCID, despite 
the increase in cultivation time, the presence of the 
microorganism in the samples was not confirmed 
using multiplex PCR method; this concerned Staphy­
lococcus hominis ssp. hominis present in monoculture 
and Escherichia coli present in mixed culture with three 
other microorganisms. In 6 (6.7%) cases, the micro­
organisms that are not covered by BCID were cultured: 
Lactobacillus spp., Lactobacillus plantarum, Candida 
lusitaniae, Stenotrophomonas maltophilia, Acinetobac­
ter lwoffii and Haemophilus parainfluenzae. In one case, 
in a mixed culture (1.3%), Haemophilus influenzae was 
identified in PCR while H. parainfluenzae was cultured. 
Antibiotics resistance determined by detection of the 
resistance genes and by phenotypic methods showed 
good concordance. The presence of the mecA gene was 
confirmed in 30 strains of coagulase­negative staphy­
lococci, and in two strains of Staphylococcus aureus. 
In one case (3.3%) a mecA gene was found, without 
confirmation of growth of methicillin­resistant strain 
in the culture. Among six enterococci identified, no 
strains with vanA/B gene were detected. Moreover, 
no Gram­negative bacteria with resistance to carbap­
enems resulting from the presence of the blaKPC gene 
were cultured from the blood in the analysis period. 
Comparison of the results obtained using the multi­
plex PCR method (BCID) and the classical method is 
shown in Table II. 
The average time of the positive samples detection 
in the BactAlert 3D system was 23.1 h (SD ± 14.2 h), 
with a period of time from detection of positive sam­
ple to start of BCID – 3.6 hours (SD ± 4.18 h). Infor­
mation about the positive PCR results was submitted 
to a  doctor within 4.9  hours (SD ± 4.2 h) while the 
report on the culture results was presented on aver­
age in 67.7 h (SD ± 22.9 h). Blood culture is the most 
commonly used microbiological method in the diag­
nosis of sepsis. In recent years, however, research is 
being conducted on the use of rapid, more sensitive 
tests for the detection of microorganisms directly from 
the blood. Rapid identification of microorganisms in 
sepsis is crucial for the selection of appropriate treat­
ment. An adequate and early treatment significantly 





































tains a wide panel of microorganisms: bacteria and 
fungi responsible for approx. 90.0% of bloodstream 
infections, detects the most common mechanisms of 
resistance in short time, and is an important tool in 
the surveillance of bloodstream infections (Blaschke 
et al., 2012; Otlu et al., 2015; Altun et al., 2013.). In 
our study on cancer patients, BCID covered 93,3% of 
the microorganisms isolated from the blood. Similar 
results were obtained by Zheng et al. (2014) in a study 
of 166 positive blood cultures from 138 children, where 
BCID covered approximately 93.0% of cultured micro­
organisms. In most of the samples, approx. 97.0%, we 
obtained consistent identifications with both methods 
used: the genetic method and the culture method. In 
one case, we observed a growth of S. hominis ssp. homi­
nis methicillin­resistant in a culture, without confirma­
tion of presence of the microorganism with the multi­
plex PCR method. The similar results were obtained by 
Zheng et al. (2014); this microorganism was also not 
detected in one sample analysed. BCID did not detect 
the following microorganisms: C. lusitaniae, S. malto­
philia, A. lwoffii, L. spp., L. plantarum, H. parainfluen­
zae, which do not fall within the spectrum of BCID. 
According to the manufacturer’s instructions, the limi­
tation of this method is that in mixed cultures BCID 
may not correctly identify all microorganisms. In our 
study, 15 blood cultures were positive for more than one 
species of bacteria. Blaschke et al. (2012) suggested that 
the uneven growth of two species in liquid culture could 
cause that despite the positive signal from the BacT/
ALERT detection system one of the species may not 
be detected with the multiplex PCR. However, accord­
ing to Altun et al. (2013), the lower limit of detection 
(LOD) in BCID, is generally sufficient to detect patho­
gens. According to the characteristics of BCID specified 
by the manufacturer, the density of bacteria in positive 
blood culture during the test was ~ 107–108 CFU/ml. In 
our study, usually Gram­positive cocci grown in mixed 
Gram­positive bacteria Staphylococcus hominis ssp. hominis MR (9) Staphylococcus (8) mecA (8)
 Staphylococcus hominis ssp. hominis MS (3) Staphylococcus (3) mecA (1)1
 Staphylococcus epidermidis MR(16) Staphylococcus mecA (15)1
 Staphylococcus epidermidis MS (4) Staphylococcus (4)
 Staphylococcus haemolyticus MR (6) Staphylococcus mecA (6)
 Staphylococcus capitis MS (2) Staphylococcus (2)
 MSCNS (1) Staphylococcus (1)
 Staphylococcus aureus MS (4) Staphylococcus; Staphylococcus aureus (4)
 Staphylococcus aureus MR (2) Staphylococcus; Staphylococcus aureus mecA (2)
 Enterococcus faecalis (4) Enterococcus sp. (4)
 Enterococcus faecium (2) Enterococcus sp. (2)
 Streptococcus salivarius (1) Streptococcus sp. (1)
 Lactobacillus plantarum (1) ND2
 Lactobacillus spp. (1) ND2
Gram-negative bacteria Pseudomonas aeruginosa (9) Pseudomonas aeruginosa (9)
 Enterobacter cloacae (1) Enterobacteriaceae; Enterobacter cloacae (1)
 Escherichia coli (9) Enterobacteriaceae; Escherichia coli (8)
 Klebsiella pneumoniae ssp. pneumoniae (3) Enterobacteriaceae; Klebsiella pneumoniae (3)
 Stenotrophomonas maltophilia (1) ND2
 Proteus mirabilis (2) Enterobacteriaceae; Proteus sp.(2)
 Acinetobacter lwoffii (1) ND2
 Haemophilus parainfluenzae (1) ND2
 ND Haemophilus influenzae
Yeast Candida glabrata (2) Candida glabrata (2)
 Candida albicans (1) Candida albicans (1)
 Candida parapsilosis (2) Candida parapsilosis (2)
 Candida lusitaniae (1) ND2
Table II
Comparison of blood culture and multiplex PCR (BCID) results.
1 in one sample two morphological different strains of S. epidermidis; 2 not detectable in BCID panel spectrum; ND – not detected;
MR – methicillin resistant; MS – methicillin susceptible; MRCNS – methicillin resistant coagulase negative Staphylococcus
Microorganism group Culture result (no) BCID result (no)
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cultures as follows: enterococci and coagulase­negative 
staphylococci, two species of coagulase­negative staph­
ylococci as well as enterococci and yeast­like fungi. 
In these cases, we obtained full compliance of results 
in both methods. In mixed cultures of Gram­negative 
bacilli and Gram­positive cocci in one case, the system 
did not detect E. coli, despite longer culture time and 
identified H. parainfluenzae, which was not included 
in BCID. The oxacillin resistance determined by the 
presence of the mecA gene was correctly identified in 
both coagulase­negative strains of Staphylococcus and 
methicillin­resistant strains of S. aureus. Furthermore, 
in one case, the PCR system also detects the presence 
of the mecA gene, which could not be confirmed phe­
notypically. BCID correctly indicated negative results 
for vanA and vanB among enterococci. However, it 
should be noted that the system does not distinguish 
between Enterococcus faecalis and Enterococcus faecium, 
the most common species of enterococci. This is asso­ 
ciated with the choice of antibiotic for treatment, as the 
majority of E. faecium is resistant to ampicillin. This is 
a certain limitation of the panel, especially in the case of 
sepsis after surgery in the abdominal cavity. MacVane 
et al. (2016) confirmed that BCID is useful in the diag­
nosis of sepsis caused by vancomycin­resistant strains 
of Enterococcus spp. The study included 68 patients with 
bacteremia caused by VRE. The authors showed statisti­
cally significant differences in the time to identify the 
microorganism by culture and genetic methods (47.7 h 
versus 18.2 h, p < 0.001), and statistically significant dif­
ference was also shown in the time required to evalu­
ate the susceptibility to vancomycin and the time for 
the implementation of effective therapy (p < 0.001). The 
authors also pointed to a significant reduction in the 
cost of a patient’s stay in hospital, when using a genetic 
method. Otlu et al. (2015) evaluated the usefulness 
of BCID in the diagnosis of sepsis in patients under­
going liver transplantation in order to shorten the time 
needed to obtain a result in relation to the classical 
methods, automatic Vitek  II and mass spectrometry 
– Vitek MS system. These differences were significant, 
and the time to obtain the results was as follows: the 
classical method –  36.2 h (SD ± 19.2 h), automatic 
method Vitek II – 23.6 (SD ± 2.23 h) and Vitek MS 
system 19.5 h (SD ± 15.1 h). BCID identified pathogen 
within 65 to 100 minutes.
In our study, the difference in amount of time 
needed to inform the physician about the detection of 
the microorganism and its mechanisms of resistance 
using BCID compared to the time needed to obtain 
the same results by VITEK 2 Compact and E­test® 
was also statistically significant (p < 0.05). However, 
due to the 12­hours shift system, the time to transfer 
the result was longer than in the above­cited studies. 
Inglis et al. (2016) studied 149 blood cultures derived 
from 143 patients and evaluated the usefulness of BCID 
depending on the hospital referral level. The authors 
believe that BCID is particularly suitable for small labo­
ratories in regional hospitals, dominated by the most 
common microorganisms. Our research confirms that 
the panel can also be used among cancer patients after 
surgery and conservative treatment of cancer.
In conclusion, BCID identified most of the micro­
organisms present in positive blood cultures in cancer 
patients, including patients undergoing abdominal 
surgery and pelvic exenteration. It can be a very use­
ful tool in the surveillance of bloodstream infections 
providing information on the etiological agent and the 
basic mechanisms of microbial resistance. It should be 
noted, however, that the essential component of genetic 
diagnostics is culture, which remains the gold stand­
ard. Application of BCID speeds up the decision on the 
selection of appropriate treatment, because it signifi­
cantly shortens the time to provide essential informa­
tion to the doctor.
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